Ownership history in BRAIDWELL LP · 12 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2,181,598 | — | 0% | 0.46% | $15.4M | $7.05 |
| 2025 Q2 | REDUCED | 2,181,598 | -1,355,255 | -38.3% | 0.48% | $14.2M | $6.50 |
| 2025 Q1 | REDUCED | 3,536,853 | -1,337,000 | -27.4% | 0.99% | $28.0M | $7.93 |
| 2024 Q4 | UNCHANGED | 4,873,853 | — | 0% | 1.83% | $61.8M | $12.67 |
As of 2025 Q4 — sorted by position size